Indogulf Cropsciences IPO GMP Analysis: Is the Grey Market Buzz Justified?


The agrochemical sector is buzzing with excitement as Indogulf Cropsciences Limited launches its Initial Public Offering (IPO). With a robust background in crop protection products and a diversified global customer base, this IPO is drawing serious attention from retail and institutional investors alike. A key highlight? The Indogulf Cropsciences IPO GMP (Grey Market Premium), which gives early insight into investor sentiment.
Let’s dive into the complete breakdown of this IPO — covering the price band, issue size, GMP, subscription status, allotment timeline, and more.
About Indogulf Cropsciences Ltd
Indogulf Cropsciences is a Delhi-based agrochemical company that manufactures and markets a broad range of products including insecticides, herbicides, fungicides, and plant growth regulators. The company operates in both domestic and international markets and holds ISO 9001:2015 and other quality certifications. With an increasing demand for agri-inputs in India and abroad, the company is poised for further expansion.
Indogulf Cropsciences IPO: Key Details
IPO Details | Information |
Price Band | ₹105 to ₹111 per share |
Face Value | ₹10 per share |
Lot Size | 135 shares |
Minimum Investment | ₹14,985 (1 lot at ₹111) |
Issue Size | ₹200 crore |
Fresh Issue | ₹160 crore |
Offer for Sale (OFS) | ₹40 crore |
IPO Opening Date | June 26, 2025 |
IPO Closing Date | June 30, 2025 |
Allotment Date | July 1, 2025 (Tentative) |
Listing Date | July 3, 2025 (Expected on BSE & NSE) |
Anchor Investment Raised | ₹58.19 crore on June 25 at ₹111/share |
Grey Market Premium (GMP) Update
The Indogulf Cropsciences IPO GMP is currently hovering around ₹10–₹11 per share. This implies an expected listing price of around ₹121–₹122, signaling moderate interest in the grey market.
Although GMP is not an official indicator and remains speculative, it often reflects the real-time market buzz and expected listing gain. A GMP of ~₹11 on the upper price band of ₹111 represents nearly a 10% listing premium.
Subscription Status (As of Day 1)
The IPO opened on June 26, 2025, and here’s how investors responded on Day 1:
Total Subscription: ~40%
Retail Investors: 60%–69% subscribed
Non-Institutional Investors (NII): ~22%
Qualified Institutional Buyers (QIBs): ~5%
These figures suggest a stronger interest from retail investors, a common pattern in SME and agrochemical IPOs. QIB participation is likely to pick up closer to the final day.
Use of IPO Proceeds
Indogulf plans to utilize the IPO proceeds for the following:
✅ Working Capital: ₹65 crore
✅ Debt Repayment: ₹34.12 crore
✅ Setting up a Dry Flowable Plant in Haryana: ₹14 crore
✅ General Corporate Purposes: Remaining funds
This deployment shows a balanced focus on growth expansion and financial strengthening, which enhances long-term value for shareholders.
Industry & Peer Comparison
Indogulf operates in a competitive sector with listed peers like:
UPL Ltd
Rallis India
Dhanuka Agritech
Insecticides (India) Ltd
Compared to these, Indogulf’s valuation appears modest, especially given its expansion plans and growing revenue base. Investors must look closely at its financials in the red herring prospectus to judge profitability and scalability.
Should You Apply?
Here’s a quick checklist to help you decide:
✅ GMP of ₹10–₹11 suggests early listing gains
✅ Focused use of proceeds in expansion and debt reduction
✅ Strong retail subscription on Day 1
⚠️ Moderate QIB interest may need closer tracking
⚠️ Check full financials before applying heavily
If you’re a retail investor looking for medium-term returns or potential listing gains, this IPO appears promising — especially in a growing sector like agrochemicals.
Final Thoughts
The Indogulf Cropsciences IPO GMP clearly reflects positive investor sentiment. While grey market trends are encouraging, always evaluate the fundamentals, industry trends, and peer valuation before making a final decision. The IPO is well-structured, with a clear growth trajectory, and could be a strong contender in the SME space if listing sentiment holds.
Subscribe to my newsletter
Read articles from abhi finowings directly inside your inbox. Subscribe to the newsletter, and don't miss out.
Written by
